Vesencumab (Anti-NRP1 / VEGF165R / CD304)

Synonyms: MNRP-1685A

Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

Vesencumab (Anti-NRP1 / VEGF165R / CD304)

Purity & Quality Control

Batch: A268201 Purity: 99% Protein concentration: 11.69mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

Product Details

CAS No. 1205533-60-3
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vesencumab (Anti-NRP1 / VEGF165R / CD304) | Vesencumab (Anti-NRP1 / VEGF165R / CD304) supplier | purchase Vesencumab (Anti-NRP1 / VEGF165R / CD304) | Vesencumab (Anti-NRP1 / VEGF165R / CD304) cost | Vesencumab (Anti-NRP1 / VEGF165R / CD304) manufacturer | order Vesencumab (Anti-NRP1 / VEGF165R / CD304) | Vesencumab (Anti-NRP1 / VEGF165R / CD304) distributor